A Patient-Derived Xenograft Model of Parameningeal Embryonal Rhabdomyosarcoma for Preclinical Studies

Figure 2

Preclinical testing of lestaurtinib in a parameningeal PDX. (a, b) Kaplan-Meier analysis of PDX mice from two different treatment cohorts.

(a)

(b)